Provided by Tiger Trade Technology Pte. Ltd.

LIVZON PHARMA

24.980
0.000
Volume:888.24K
Turnover:22.22M
Market Cap:22.18B
PE:9.35
High:25.140
Open:24.980
Low:24.820
Close:24.980
52wk High:28.238
52wk Low:18.750
Shares:888.00M
HK Float Shares:300.00M
Volume Ratio:0.67
T/O Rate:0.30%
Dividend:2.83
Dividend Rate:11.32%
EPS(LYR):2.670
ROE:12.42%
ROA:5.31%
PB:1.45
PE(LYR):9.35
PS:1.84

Loading ...

Livzon Pharma to Distribute Q3 Dividend of RMB 12.39 per 10 Shares on December 23

Deep News
·
Nov 16

Livzon Pharma to Distribute Q3 Dividend of RMB12.39 per 10 Shares on December 23

Stock News
·
Nov 13

Livzon Pharma Declares Q3 Dividend of RMB 12.39 per 10 Shares, Payable on 23 December 2026

Bulletin Express
·
Nov 12

Livzon Pharma Confirms RMB1.10 Billion Q3 Dividend, Shareholder Return Plan and Adds New Non-Executive Director

Bulletin Express
·
Nov 12

Livzon Pharma Announces Updated Board and Committee Line-up

Bulletin Express
·
Nov 12

Livzon Pharma to Distribute Q3 Dividend of HK$14.47 per 10 Shares on December 23

Stock News
·
Nov 12

Livzon Pharma to Acquire Roughly 0.13% Stake in Xinbeijiang Pharmaceutical from Zhonghuiyuan

Stock News
·
Nov 11

Joincare Pharmaceutical Grants 590 Million Yuan in Guarantees to Subsidiaries in October

MT Newswires Live
·
Nov 05

Livzon Pharma Reports No Share Capital Changes in October; Confirms Public Float Compliance

Bulletin Express
·
Nov 02

Livzon Pharmaceutical Gets China Trial Clearance for Two Drug Candidates

MT Newswires Live
·
Oct 27

Livzon Pharmaceutical Secures China Marketing Approval for Traditional Chinese Medicine

MT Newswires Live
·
Oct 27

Livzon Pharmaceutical Receives NMPA Drug Clinical Trial Approval for Tiange Dingxuan Granules

Reuters
·
Oct 27

Livzon Pharma Wins NMPA Nod to Begin Clinical Trials of First-in-Class Tiange Dingxuan Granules for Vestibular Migraine

Bulletin Express
·
Oct 27

Livzon Pharma's Subsidiary Gains Drug Registration Certificate for Wandaitang Granules

Stock News
·
Oct 27

Livzon Pharma Gains Approval for Clinical Trial of Recombinant Humanized Anti-FXI Bispecific Antibody Injection for Preventing VTE After Total Knee Replacement

Stock News
·
Oct 27

AH Premium Statistics for October 26: Northeast Electric Tops Premium Rankings

Stock News
·
Oct 26

Livzon Pharma Jumps Over 10% in Morning Session on Generous Dividend Payout and Three-Year Shareholder Return Plan

Deep News
·
Oct 26

Livzon Pharma Announces RMB 12.39 Cash Dividend per 10 Shares for Q3 2026, Payment Slated for 23 December 2026

Bulletin Express
·
Oct 23

LIVZON PHARMA Publishes 2026 Q3 Report, Calls Second EGM and Unveils 2026-2028 Shareholder Return Plan

Bulletin Express
·
Oct 23

Livzon Pharma Publishes 2026 Q3 Report, Profit Distribution Proposal and 2026–2028 Shareholder Return Plan

Bulletin Express
·
Oct 23